EX-99.4 4 tm203780d1_ex99-4.htm EXHIBIT 99.4

 

Exhibit 99.4

 

UNAUDITED PRO FORMA CONDENSED

COMBINED FINANCIAL INFORMATION OF ADAPTHEALTH CORP.

 

The following unaudited pro forma condensed combined information presents the unaudited pro forma condensed combined balance sheet as of September 30, 2019 and the unaudited pro forma condensed combined statements of operations for the nine months ended September 30, 2019 and the year ended December 31, 2018 based upon the combined historical financial statements of AdaptHealth Corp.’s subsidiary, AdaptHealth Holdings LLC (“AdaptHealth”), and the Patient Care Solutions business (“PCS”) after giving effect to AdaptHealth Corp.’s acquisition of PCS from McKesson Corporation (the “PCS Acquisition”) and related adjustments described in the accompanying notes.

 

The unaudited pro forma condensed combined statements of operations for the nine months ended September 30, 2019 and for the year ended December 31, 2018 give pro forma effect to the PCS Acquisition as if it had occurred on January 1, 2018. The unaudited pro forma condensed combined balance sheet as of September 30, 2019 gives pro forma effect to the PCS Acquisition as if it was completed on September 30, 2019.

 

The unaudited pro forma condensed combined financial information should be read in conjunction with the following:

 

·The audited historical financial statements of AdaptHealth and the notes thereto as included in the Proxy Statement filed on October 23, 2019.

 

·The unaudited historical financial statements of AdaptHealth and the notes thereto as included in the Current Report on Form 8-K filed on November 14, 2019.

 

·The audited and unaudited historical financial statements of PCS and the notes thereto included elsewhere in this Current Report on Form 8-K/A.

 

The unaudited pro forma condensed combined financial information is provided for informational purposes only and is not necessarily indicative of the operating results or financial position that would have occurred if the PCS Acquisition had been completed as of the dates set forth above, nor is it indicative of the future results or financial position of the combined company. The unaudited pro forma condensed combined financial information also does not give effect to the potential impact, of any anticipated synergies, operating efficiencies or cost savings resulting from favorable vendor pricing had AdaptHealth Corp. owned PCS in the periods indicated above, or any integration costs and benefits from restructuring plans.

 

 

 

 

ADAPTHEALTH CORP.

UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET

September 30, 2019

 

   AdaptHealth                
   Holdings LLC   PCS   Pro Forma      Pro Forma 
(in thousands)  Historical   Reclassified (1)   Adjustments   Note 3  Combined 
Assets                       
Current assets:                       
Cash and cash equivalents  $8,823   $19,478   $(19,480)  (a)  $8,821 
Accounts receivable, net   73,670    19,647    -       93,317 
Inventory   14,234    -    -       14,234 
Prepaid and other current assets   6,350    843    (725)  (b)   6,468 
Total current assets   103,077    39,968    (20,205)      122,840 
Equipment and other fixed assets, net   66,706    8,639    -       75,345 
Goodwill   245,346    -    -       245,346 
Other assets   5,893    10,249    (10,234)  (c)   5,908 
Deferred tax asset   6,965    -    -       6,965 
Total assets  $427,987   $58,856   $(30,439)     $456,404 
                        
Liabilities and Stockholders'/Members' Equity (Deficit)                       
Current liabilities:                       
Accounts payable and accrued expenses  $90,456   $4,012   $(1,386)  (d)  $93,082 
Current portion of capital lease obligations   21,656    -    -       21,656 
Current portion of long-term debt   8,894    -    -       8,894 
Deferred revenue   9,097    -    -       9,097 
Other liabilities   8,609    2,983    (2,983)  (e)   8,609 
Total current liabilities   138,712    6,995    (4,369)      141,338 
Long-term debt, less current portion   410,538    -    15,000   (f)   425,538 
Capital lease obligations, less current portion   236    -    -       236 
Other long-term liabilities   15,199    8,722    (8,627)  (g)   15,294 
Total liabilities   564,685    15,717    2,004       582,406 
                        
Commitments and contingencies                       
Total stockholders'/members' equity (deficit)   (139,561)   43,139    (32,443)   (h)   (128,865)
Total stockholders'/members' equity (deficit) attributable to AdaptHealth Holdings LLC     (139,561 )     3,139       (32,443 )         (128,865 )
Noncontrolling interest in subsidiaries   2,863    -    -       2,863 
Total stockholders'/members' equity (deficit)   (136,698)   43,139    (32,443)      (126,002)
Total Liabilities and Stockholders'/Members' Equity (Deficit)  $427,987   $58,856   $(30,439)     $456,404 

 

 

(1)Refer to Note 2 for reclassification of PCS historical information.

 

 

 

 

ADAPTHEALTH CORP.

UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019

 

   AdaptHealth                
   Holdings LLC   PCS   Pro Forma      Pro Forma 
(in thousands except share and per share amounts)  Historical   Reclassified (1)   Adjustments   Note 3  Combined 
Revenue:                       
Revenue, net of contractual allowances and discounts  $400,958   $99,955   $-      $500,913 
Provision for doubtful accounts   (20,855)   (738)   -       (21,593)
Net revenue less provision for doubtful accounts   380,103    99,217    -       479,320 
Costs and expenses:                       
Cost of net revenue   317,174    122,845    -       440,019 
General and administrative expenses   31,508    4,165    -       35,673 
Depreciation, excluding patient equipment depreciation   2,439    727    -       3,166 
Total costs and expenses   351,121    127,737    -       478,858 
Operating (loss) income   28,982    (28,520)   -       462 
Interest (income) expense   31,651    (75)   552   (i)   32,128 
Loss on extinguishment of debt, net   2,121    -    -       2,121 
Income before income taxes   (4,790)   (28,445)   (552)      (33,787)
Income tax expense   5,444    -    -       5,444 
Net income   (10,234)   (28,445)   (552)      (39,231)
Income attributable to noncontrolling interest   1,336    -    -       1,336 
Net income attributable to AdaptHealth Holdings LLC  $(11,570)  $(28,445)  $(552)     $(40,567)

 

 

 

(1)Refer to Note 2 for reclassification of PCS historical information.

 

 

 

 

ADAPTHEALTH CORP.

UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS

FOR THE YEAR ENDED DECEMBER 31, 2018

 

   AdaptHealth                
   Holdings LLC   PCS   Pro Forma      Pro Forma 
(in thousands except share and per share amounts)  Historical   Reclassified (1)   Adjustments   Note 3  Combined 
Revenue:                       
Revenue, net of contractual allowances and discounts  $361,054   $136,321   $-      $497,375 
Provision for doubtful accounts   (15,776)   (1,547)   -       (17,323)
Net revenue less provision for doubtful accounts   345,278    134,774    -       480,052 
Costs and expenses:                       
Cost of net revenue   293,384    173,308    -       466,692 
General and administrative expenses   18,069    5,253    -       23,322 
Depreciation, excluding patient equipment depreciation   2,734    314    -       3,048 
Total costs and expenses   314,187    178,875    -       493,062 
Operating (loss) income   31,091    (44,101)   -       (13,010)
Interest (income) expense   7,453    (72)   737   (i)   8,118 
Loss on extinguishment of debt, net   1,399    -    -       1,399 
Income before income taxes   22,239    (44,029)   (737)      (22,527)
Income tax benefit   (2,098)   -    -       (2,098)
Net income   24,337    (44,029)   (737)      (20,429)
Income attributable to noncontrolling interest   1,077    -    -       1,077 
Net income attributable to AdaptHealth Holdings LLC  $23,260   $(44,029)  $(737)     $(21,506)

  

 

 

(1)Refer to Note 2 for reclassification of PCS historical information.

 

 

 

 

NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS

 

Note 1—Description of the PCS Acquisition

 

Basis of presentation

 

The historical financial information has been adjusted in the unaudited pro forma condensed combined financial information to give effect to events that are (1) directly attributable to the PCS Acquisition, (2) factually supportable, and (3) with respect to the statement of operations, expected to have a continuing impact on the combined results. The pro forma adjustments are prepared to illustrate the estimated effect of the PCS Acquisition.

 

AdaptHealth’s historical results reflect AdaptHealth’s audited consolidated statement of operations for the year ended December 31, 2018, unaudited condensed consolidated balance sheet as of September 30, 2019 and unaudited condensed consolidated statement of operations for the nine months ended September 30, 2019. PCS’ historical results reflect the audited combined statement of operations for PCS’ fiscal year ended March 31, 2019, unaudited condensed combined balance sheet as of September 30, 2019 and unaudited condensed combined statement of operations for the nine months ended September 30, 2019.

 

Description of the PCS Acquisition

 

On November 21, 2019, AdaptHealth LLC, a Delaware limited liability company (“Buyer”) and a wholly-owned indirect subsidiary of AdaptHealth Corp., McKesson Medical-Surgical, Inc., a Virginia corporation (“Seller”), NRE Holding Corporation, a Delaware corporation (“NRE”), and McKesson Patient Care Solutions, Inc., a Pennsylvania corporation, entered into a Securities Purchase Agreement (the “Agreement”), pursuant to which Seller agreed to sell to Buyer, and Buyer agreed to purchase from the Seller, all of the issued and outstanding equity interests of NRE (the “Transaction”). The Transaction closed on January 1, 2020 upon satisfaction of all closing conditions pursuant to the Agreement. In connection with the Transaction, AdaptHealth Corp. acquired PCS from McKesson Corporation. PCS provides wound care supplies, ostomy supplies, urological supplies, incontinence supplies, diabetic care supplies, and breast pumps directly to patients across the United States. PCS maintains extensive national relationships with physicians, medical facilities and customers, and currently serves all 50 states.

 

  The base purchase price for the Transaction was $14.0 million, subject to customary adjustments for cash, indebtedness, transaction expenses and net working capital (as compared to an agreed target net working capital amount). The total cash paid at closing was $15.0 million. In addition, Buyer may be required to make an additional payment of $1.5 million to Seller after the closing of the Transaction pursuant to the terms and conditions of a Transition Services Agreement executed in connection with the Transaction. The total investment, including restructuring costs until the business is fully integrated on AdaptHealth Corp.’s platform in the latter half of 2020, is expected to be approximately $30 million.

 

The following table summarizes the preliminary allocation of the purchase price to the estimated fair values of the net assets acquired at the date of the Transaction. AdaptHealth Corp. is still in the process of finalizing the purchase price allocation.

 

(in thousands)    
Cash consideration  $15,002 
      
Fair value of net assets acquired:     
Accounts receivables  $19,647 
Prepaid and other current assets   118 
Other assets   15 
Equipment and other fixed assets   8,639 
Accounts payable and accrued expenses   (2,626)
Other liabilities   (95)
Net assets acquired  $25,698 
Bargain purchase gain  $10,696 

 

 

 

Management of AdaptHealth Corp. will finalize the measurement of the separately identifiable assets acquired and the liabilities assumed at the acquisition date in accordance with the requirements of FASB ASC Topic 805, Business Combinations. In accordance with FASB ASC Topic 805, management will review the procedures it uses to identify and measure the assets acquired and liabilities assumed in order to ensure that the measurements appropriately reflect the consideration of all available information as of the acquisition date. Based on the information currently available to management, it is estimated that a bargain purchase gain will be recorded in connection with the PCS Acquisition. Management has determined that a gain on this transaction may be appropriate given the Seller desired to exit the home medical equipment business operated by PCS.

 

Basis of the Pro Forma Presentation

 

Upon consummation of the PCS Acquisition, PCS will adopt AdaptHealth Corp.’s accounting policies. AdaptHealth Corp. may identify differences between the accounting policies among the companies, that when conformed, could have a material impact on the consolidated financial statements of the combined entity.

 

Note 2—Reclassifications to Historical Financial Information of PCS

 

Certain balances and transactions presented in the historical financial statements of PCS included within the unaudited pro forma condensed combined financial information have been reclassified to conform to the presentation of financial statements of AdaptHealth as indicated in the tables below.

 

 

 

PCS Balance Sheet Reclassifications at September 30, 2019

 

   As per         
(in thousands)  Financial
Statements
   Reclassifications   As
Reclassified
 
Assets               
Accounts receivable, net  $12,762   $6,885   $19,647 
Contract Assets   6,885    (6,885)   - 
                
Liabilities and Stockholders'/Members' Equity (Deficit)               
Current liabilities:               
Accounts payable and accrued expenses   751    3,261    4,012 
Other accrued liabilities   6,244    (6,244)   - 
Other liabilities   -    2,983    2,983 
                
Total stockholders'/members' equity (deficit)               
Total stockholders'/members' equity (deficit) attributable to AdaptHealth Holdings LLC   -    43,139    43,139 
Net parent investment   43,139    (43,139)   - 

 

PCS Statement of Operations Reclassifications for the Nine Months Ended September 30, 2019

 

   As per         
(in thousands)  Financial
Statements
   Reclassifications   As
Reclassified
 
Revenue:               
Revenue, net of contractual allowances and discounts  $99,217   $738   $99,955 
Provision for doubtful accounts   -    (738)   (738)
Costs and expenses:               
Cost of net revenue   60,310    62,535    122,845 
General and administrative expenses   -    4,165    4,165 
Depreciation, excluding patient equipment depreciation   -    727    727 
Selling, distribution, and administrative expenses   63,346    (63,346)   - 
Restructuring Charges   4,090    (4,090)   - 
Interest (income) expense   -    (75)   (75)
Other expense, net   (84)   84    - 

 

PCS Statement of Operations Reclassification for the Year Ended March 31, 2019

 

   As per         
(in thousands)  Financial
Statements
   Reclassifications   As
Reclassified
 
Revenue:               
Revenue, net of contractual allowances and discounts  $134,774   $1,547   $136,321 
Provision for doubtful accounts   -    (1,547)   (1,547)
Costs and expenses:               
Cost of net revenue   84,995    88,313    173,308 
General and administrative expenses   -    5,253    5,253 
Depreciation, excluding patient equipment depreciation   -    314    314 
Selling, distribution, and administrative expenses   86,269    (86,269)   - 
Restructuring Charges   7,601    (7,601)   - 
Interest (income) expense   -    (72)   (72)
Other expense, net   (62)   62    - 

 

 

 

Note 3—Pro Forma Adjustments

 

Adjustments to the Unaudited Pro Forma Condensed Combined Balance Sheet (in thousands)

 

The pro forma adjustments included in the unaudited pro forma condensed combined balance sheet as of September 30, 2019 are as follows:

 

a)Represents the following adjustments (1) reduction of $19,478 representing PCS’ September 30, 2019 cash balance since cash was not acquired in connection with the PCS Acquisition, (2) payment of $15,002 representing the cash paid at closing of the PCS Acquisition, and (3) proceeds from debt of $15,000 to fund the cash portion of the purchase price of the PCS Acquisition. It is noted that while AdaptHealth Corp. did not finance the PCS Acquisition by incurring debt when the closing occurred, the pro-forma adjustments include debt financing since AdaptHealth did not have enough cash at September 30, 2019 to fund the PCS Acquisition.

 

b)Represents adjustment to reflect certain assets included in the historical September 30, 2019 balance sheet of PCS that were not acquired by AdaptHealth Corp.

 

c)Represents adjustment to reflect operating lease right-of-use assets included in the historical September 30, 2019 balance sheet of PCS as a result of PCS’ adoption of amended accounting guidance related to lease arrangements. This is included as a pro-forma adjustment since AdaptHealth Corp. has not yet adopted such accounting guidance.

 

d)Represents adjustment to reflect certain accrued expenses included in the historical September 30, 2019 balance sheet of PCS that were not assumed by AdaptHealth Corp.

 

e)Represents adjustments to reflect (1) restructuring liablities of $1,376 included in the historical September 30, 2019 balance sheet of PCS that were not assumed by AdaptHealth Corp., and (2) operating lease liabilities of $1,607 included in the historical September 30, 2019 balance sheet of PCS as a result of PCS’ adoption of amended accounting guidance related to lease arrangements. This is included as a pro-forma adjustment since AdaptHealth Corp. has not yet adopted such accounting guidance.

 

f)Represents proceeds from debt to fund the cash portion of the purchase price of the PCS Acquisition. It is noted that while AdaptHealth Corp. did not finance the PCS Acquisition by incurring debt when the closing occurred, the pro-forma adjustments include debt financing since AdaptHealth did not have enough cash at September 30, 2019 to fund the PCS Acquisition.

 

g)Represents adjustment to reflect operating lease liabilities included in the historical September 30, 2019 balance sheet of PCS as a result of PCS’ adoption of amended accounting guidance related to lease arrangements. This is included as a pro-forma adjustment since AdaptHealth Corp. has not yet adopted such accounting guidance.

 

h)Represents adjustment to equity resulting from the preliminary estimated acquisition accounting in connection with the PCS Acquisition. This includes the impact of an estimated $10.7 million bargain purchase gain, calculated as if the net assets of PCS were acquired on September 30, 2019. The bargain purchase gain is not reflected in the unaudited pro forma combined statements of operations because it is a nonrecurring item that is directly related to the transaction.

 

Adjustments to the Unaudited Pro Forma Condensed Combined Statements of Operations

 

The pro forma adjustments included in the unaudited pro forma condensed combined statement of operations for the nine month period ended September 30, 2019 and for the fiscal year ended December 31, 2018 are as follows:

 

i)Represents adjustments to include incremental interest expense for borrowings on the AdaptHealth revolver with an interest rate of 5.41%, offset by lower undrawn revolver fees. It is noted that while AdaptHealth Corp. did not finance the PCS Acquisition by incurring debt when the closing occurred, the pro-forma adjustments include debt financing since AdaptHealth Corp. did not have enough cash at September 30, 2019 to fund the PCS Acquisition.